Last updated on November 2019

An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus


Brief description of study

This Phase II, multicenter, open-label extension (OLE) study will evaluate the long-term safety and efficacy of GDC-0853 in participants with systemic lupus erythematosus (SLE) who have completed Study GA30044 (NCT02908100) up to 48 weeks.

Clinical Study Identifier: NCT03407482

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.